New drug helps boost cancer treatment
...erapy drugs thereby extending survival of advanced colorectal cancer patients. IMC-C225, the new drug which is actually a monoclonal antibody, is designed to interfere with the epidermal growth factor receptor, a molecular structure that, when blocked, makes it more difficult for tumor cells to reproduce. To......e American Cancer Society. As many as 12% of all colorectal cancer deaths in the US may be caused by tobacco s...Society study and other large studies suggest that colorectal cancer should be considered for classification as a smoking-related cancer". Among men, current smo...